A phase 1 evaluation of the safety and tolerability of niraparib in combination with everolimus in advanced ovarian and breast cancers

OBJECTIVES: Phase 1 trial to determine the safety and tolerability of everolimus and niraparib in patients with advanced ovarian and breast malignancies. RESULTS: Fourteen heavily pretreated patients were enrolled (12 high‐grade serous ovarian cancer, 1 clear cell ovarian cancer, and 1 triple negati...

Descripción completa

Detalles Bibliográficos
Autores principales: Starks, David, Rojas‐Espaillat, Luis, Meissner, Tobias, Elsey, Rachel, Xu, Bing, Koenen, Maria, Feng, Shelley, VanOosbree, Annika, Slunecka, John, Lee, John, Williams, Casey B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557865/
https://www.ncbi.nlm.nih.gov/pubmed/37644890
http://dx.doi.org/10.1002/cam4.6475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557865/
https://www.ncbi.nlm.nih.gov/pubmed/37644890
http://dx.doi.org/10.1002/cam4.6475

Ejemplares similares